XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, diabe…
$0.91-1.09%
报价 2026-11-06
市值
$1.7M
EV
$932,702
PE (TTM)
–
预期 PE
–
52 周区间距高点 -71.9%
$0.91$3.24
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Biotechnology| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| XRTXXORTX Therapeutics Inc. | $1.7M | -1.1% | – | 0% | – | – | – | |
| CLDICalidi Biotherapeutics, Inc. | $1.8M | +3.1% | – | 0% | – | – | – | |
| CRISCuris, Inc. | $1.8M | +6.6% | -84.3% | 99.3% | – | – | – | |
| KAPAKairos Pharma, Ltd. | $1.7M | +7.3% | – | 0% | – | – | – | |
| CELZCreative Medical Technology Holdings, Inc. | $1.6M | +2.6% | +1118724.9% | -1,732.4% | – | – | – | |
| GOVXGeoVax Labs, Inc. | $1.6M | -0.1% | +4.0% | 0% | – | – | – | |
| RNAZTransCode Therapeutics, Inc. | $1.6M | -1.3% | -50.0% | 0% | – | – | – | |
| OGENOragenics, Inc. | $1.6M | +0.0% | – | – | – | – | – | |
| SILOSilo Pharma, Inc. | $1.5M | +3.1% | 0.0% | -474.3% | – | – | – | |
| 同行中位数 | – | – | 0.0% | 0% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。
研究材料
Filing 摘要
电话会纪要摘要
暂无纪要摘要。